Arrivent Biopharma, Common Stock Analysis
| AVBP Stock | 27.45 0.86 3.23% |
ArriVent BioPharma, Common is overvalued with Real Value of 23.77 and Hype Value of 27.45. The main objective of ArriVent BioPharma, stock analysis is to determine its intrinsic value, which is an estimate of what ArriVent BioPharma, Common is worth, separate from its market price. There are two main types of ArriVent BioPharma,'s stock analysis: fundamental analysis and technical analysis.
The ArriVent BioPharma, stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. ArriVent BioPharma, is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. ArriVent Stock trading window is adjusted to America/New York timezone.
ArriVent |
ArriVent Stock Analysis Notes
About 14.0% of the company shares are held by company insiders. The book value of ArriVent BioPharma, was presently reported as 8.85. The company recorded a loss per share of 2.24. ArriVent BioPharma, had not issued any dividends in recent years. For more info on ArriVent BioPharma, Common please contact the company at 628-277-4836 or go to https://www.arrivent.com.ArriVent BioPharma, Investment Alerts
| ArriVent BioPharma, had very high historical volatility over the last 90 days | |
| ArriVent BioPharma, has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (69.33 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ArriVent BioPharma, generates negative cash flow from operations | |
| About 65.0% of the company shares are held by institutions such as insurance companies |
ArriVent Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 798 M.Technical Drivers
As of the 25th of November, ArriVent BioPharma, shows the Risk Adjusted Performance of 0.0188, downside deviation of 4.08, and Mean Deviation of 2.72. ArriVent BioPharma, technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.ArriVent BioPharma, Price Movement Analysis
The output start index for this execution was eleven with a total number of output elements of fifty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. ArriVent BioPharma, middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for ArriVent BioPharma,. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
ArriVent BioPharma, Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ArriVent BioPharma, insiders, such as employees or executives, is commonly permitted as long as it does not rely on ArriVent BioPharma,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ArriVent BioPharma, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Hillhouse Investment Management, Ltd. over two months ago Acquisition by Hillhouse Investment Management, Ltd. of 555555 shares of ArriVent BioPharma, at 18.0 subject to Rule 16b-3 | ||
Hillhouse Investment Management Ltd over six months ago Conversion by Hillhouse Investment Management Ltd of 3616041 shares of ArriVent BioPharma, | ||
Gordon Carl L over six months ago Conversion by Gordon Carl L of 821827 shares of ArriVent BioPharma, | ||
Gordon Carl L over six months ago Conversion by Gordon Carl L of 469615 shares of ArriVent BioPharma | ||
Jallal Bahija over six months ago Acquisition by Jallal Bahija of 17884 shares of ArriVent BioPharma, subject to Rule 16b-3 | ||
Gordon Carl L over six months ago ArriVent BioPharma exotic insider transaction detected |
ArriVent BioPharma, Predictive Daily Indicators
ArriVent BioPharma, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ArriVent BioPharma, stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
ArriVent BioPharma, Forecast Models
ArriVent BioPharma,'s time-series forecasting models are one of many ArriVent BioPharma,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ArriVent BioPharma,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding ArriVent BioPharma, to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
| All Next | Launch Module |
Additional Tools for ArriVent Stock Analysis
When running ArriVent BioPharma,'s price analysis, check to measure ArriVent BioPharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ArriVent BioPharma, is operating at the current time. Most of ArriVent BioPharma,'s value examination focuses on studying past and present price action to predict the probability of ArriVent BioPharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ArriVent BioPharma,'s price. Additionally, you may evaluate how the addition of ArriVent BioPharma, to your portfolios can decrease your overall portfolio volatility.